| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $116.61B | -1.1% |
| Cost of Revenue | $25.25B | +11.5% |
| R&D Expense | $35.34B | +43.3% |
| SG&A Expense | $11.82B | +20.2% |
| Operating Income | $28.94B | -38.1% |
| Pre-tax Income | $28.82B | -39.1% |
| Income Tax | $5.62B | -29.0% |
| Net Income | $23.20B | -41.1% |
| EPS (Basic) | $8.63 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.68B | -11.6% |
| Short-term Investments | $26.06B | -17.0% |
| Accounts Receivable | $13.47B | -4.1% |
| Current Assets | $59.55B | -10.7% |
| Total Assets | $185.73B | +11.9% |
| Current Liabilities | $27.03B | +27.9% |
| Long-term Debt | $9.92B | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.48B | -12.5% |
| Capital Expenditures | $31.43B | +69.3% |
| Investing Cash Flow | -$28.97B | -282.7% |
| Financing Cash Flow | -$22.14B | +56.4% |
| Free Cash Flow | $19.04B | -51.3% |
| -38.3% |
| EPS (Diluted) | $8.59 | -37.6% |
| Total Liabilities |
| $60.01B |
| +46.0% |
| Stockholders' Equity | $125.71B | +0.7% |